Paper
CrystEngComm
123.52, 123.29, 122.82, 122.80, 60.94 (OCH3), 47.86 (Im–CH2–
Im–H), 7.16 (s, 2H, Ph–H) (Ph = benzene), 5.41 (s, 4H, Im–CH2–
Ph), 3.86 (s, 6H, Im–CH3), 3.76 (s, 3H, –OCH3), 2.26 (s, 3H, Im–
CH3); 13C NMR (100 MHz, DMSO-d6): d 154.04 (C–OCH3 of Ph),
136.81 (NCHN of Im), 134.63 (C–CH3 of Ph), 131.37, 128.13,
123.84, 122.53 (Im), 62.09 (OCH3), 47.26 (Im–CH2–Ph), 35.81
(Im–CH3), 20.23 (CH3–Ph). ESI-MS [M 2 PF62]+: at m/z 457.2.
Anal. calcd for C18H24F12N4OP2: C, 47.27; H, 5.29; N, 12.25.
Found: C, 47.24; H, 5.18; N, 12.45.
[1-(Tert-butyl)-3,5-bis(N-methylimidazol-2-yl)methyl-4-meth-
oxybenzene] hexafluorophosphate 5b: 79%. 1H NMR (400
MHz, DMSO-d6): d 9.11 (s, 2H, Im–H), 7.70 (s, 4H, Im–H), 7.47
(s, 2H, Ph–H), 5.42 (s, 4H, Im–CH2–Ph), 3.86 (s, 6H, Im–CH3),
3.76 (s, 3H, Ph–OCH3), 1.26 (s, 9H, t-Bu); 13C NMR (100 MHz,
DMSO-d6): d 154.43 (C–OCH3 of Ph), 147.91 (C–t-Bu of Ph),
136.66 (NCHN of Im), 128.74, 127.68, 123.80, 122.44 (Im),
62.08 (OCH3), 47.71 (Im–CH2–Ph), 35.82 (Im–CH3), 34.31
(t-Bu), 30.93 (CH3 of t-Bu). ESI-MS: [M 2 PF62]+: at m/z
499.2. Anal. calcd for C21H30F12N4OP2: C, 39.14; H, 4.69; N,
8.69. Found: C, 39.04; H, 4.88; N 8.69.
[1-Methyl-3,5-bis(N-naphthylmethylimidazol-2-yl)methyl-4-
methoxybenzene] hexafluorophosphate 5c: 89%. 1H NMR (400
MHz, DMSO-d6): d 9.32 (s, 2H, Im–H), 8.10 (m, 2H, Naph–H)
(Naph = Naphthalene), 8.04 (d, 4H, J = 8.0 Hz, Naph–H), 7.82
(s, 2H, Im–H), 7.69 (s, 2H, Im–H), 7.63–7.51 (m, 8H, Im–H and
Naph–H), 7.01 (s, 2H, Ph–H), 5.94 (s, 4H, Naph–CH2–Im), 5.40
(s, 4H, Im–CH2–Ph), 3.60 (s, 3H, –OCH3), 2.19 (s, 3H, –CH3);
13C NMR (100 MHz, DMSO-d6): d 153.92 (C–OCH3 of Ph),
136.76 (NCHN of Im), 134.55 (C–CH3 of Ph), 133.44, 131.01,
130.33, 129.89, 129.74, 127.17, 126.45, 125.64, 123.08, 122.93,
122.72, 61.81 (OCH3), 50.08 (Im–CH2–Naph), 47.52 (Im–CH2–
Ph), 20.25 (CH3–Ph). ESI-MS [M 2 PF62]+: at m/z 709.3. Anal.
calcd for C38H36F12N4OP2: C, 53.40; H, 4.25; N, 6.56. Found: C,
53.19; H, 4.29; N, 5.75.
[1-Methyl-3,5-bis(N-anthrylmethylimidazol-2-yl)methyl-4-
methoxybenzene] hexafluorophosphate 5d: 75%. 1H NMR (400
MHz, DMSO-d6): d 9.04 (s, 2H, Im–H), 8.86 (s, 4H, An–H), (An
= anthracene), 8.45 (d, 4H, J = 11.2 Hz, An–H), 8.23 (d, 4H, J =
10.8 Hz, An–H), 7.70–7.59 (m, 12H, Im–H and An–H), 6.83 (s,
2H, Ph–H), 6.51 (s, 4H, An–CH2–Im), 5.28 (s, 4H, Im–CH2–
Ph), 3.40 (s, 3H, –OCH3), 2.12 (s, 3H, –CH3); 13C NMR (100
MHz, DMSO-d6): d 153.54 (C–OCH3 of Ph), 136.12 (NCHN of
Im), 134.36 (C–CH3 of Ph), 131.06, 130.57, 130.33, 130.16,
129.42, 128.27, 122.75, 126.59, 123.43, 123.26, 122.91,
122.77, 125.59, 123.43, 123.26, 122.91, 122.77, 61.51
(OCH3), 47.25 (Im–CH2–An), 45.02 (Im–CH2–Ph), 20.27
(CH3–Ph). ESI-MS [M 2 PF62]+: at m/z 809.3. Anal. calcd
for C46H40F12N4OP2: C, 57.87; H, 4.22; N, 5.87. Found: C,
57.84; H, 4.12; N, 5.57.
An), 44.99 (Im–CH2–Ph), 28.33 (Ph–CH2–Ph), 20.38 (CH3–Ph).
2 +
ESI-MS [M
2
PF6
]
at m/z 943.4. Anal. calcd for
C
55H50F12N4O2P2: C, 60.66; H, 4.63; N, 5.15. Found: C, 60.39;
H, 4.63; N, 5.07.
5f: 68%. 1H NMR (400 MHz, DMSO-d6): d 9.09 (s, 2H,
NCHN), 8.86 (s, 2H, An–H), 8.48 (d, 4H, J = 8.8 Hz, An–H), 8.23
(d, 4H, J = 8.8 Hz, An–H), 7.69–7.60 (ddd, 12H, J = 17.5, 14.8,
6.2 Hz, An–H, Im–H), 7.02 (d, 2H, J = 2.1 Hz, Ph–H), 6.95 (d,
2H, J = 2.1 Hz, Ph–H), 6.92 (s, 2H, Ph–H), 6.55 (s, 4H, An–CH2),
5.35 (s, 4H, Im–CH2–Ph), 3.96 (s, 4H, Ph–CH2–Ph), 3.51 (s, 6H,
Ph–OCH3 with Im), 3.44 (s, 3H, middle Ph–OCH3), 1.07 (d,
27H, J = 16.1 Hz, t-Bu). 13C NMR (100 MHz, DMSO-d6): d 152.91
(C–OCH3 of Ph), 152.70 (C–OCH3 of Ph), 145.35 (C–t-Bu of Ph),
144.60 (C–t-Bu of Ph), 134.84 (NCHN of Im), 132.43, 130.94,
129.99, 129.49, 129.05, 128.30, 127.21, 126.66, 125.99, 124.81,
124.46, 123.19, 122.39, 122.13, 121.71, 121.67, 59.71 (OCH3),
59.21 (OCH3), 47.08 (Im–CH2–An), 43.85 (Im–CH2–Ph), 32.80
(t-Bu), 32.71 (t-Bu), 29.88 (CH3 of t-Bu), 29.75 (CH3 of t-Bu),
27.95 (Ph–CH2–Ph). ESI-MS [M 2 PF62]+ at m/z 1203.3. Anal.
calcd for C73H78F12N4O3P2: C, 64.98; H, 5.83; N, 4.15. Found: C,
64.85; H, 5.69; N, 4.24.
General procedure for the synthesis of complexes 6a–f
A sample of precursor 5 (0.50 mmol) was dissolved in 50 mL of
acetonitrile and silver oxide (1.0 mmol) was added to the
solution. The mixture was stirred at 50 uC for 8 h with the
exclusion of light. After cooling to room temperature, the
suspension was filtered through Celite to collect the filtrate.
The volatiles were evaporated in vacuo at room temperature.
Pure complex
6 was afforded by recrystallization from
acetonitrile–ethyl ether.
6a: 82%. 1H NMR (400 MHz, DMSO-d6): d 7.47 (s, 8H, Im–H),
6.77 (s, 4H, Ph–H), 5.21 (s, 8H, Ph–CH2–Ph), 3.82 (s, 12H, Im–
CH3), 3.56 (s, 6H, Ph–OCH3), 2.04 (s, 6H, Ph–CH3); 13C NMR
(100 MHz, DMSO-d6): d 179.35 (carbene), 152.04 (C–OCH3 of
Ph), 132.80, 129.22, 128.23, 121.99, 121.43, 117.03 (Im), 60.42
(OCH3), 47.85 (Im–CH2–Ph), 37.16 (Im–CH3), 19.18 (CH3–Ph);
ESI-MS: [M 2 2PF62]2+/2: at m/z 417.3 (for 107Ag), 419.2 (for
109Ag). Anal. calcd for C36H44Ag2F12N8O2P2: C, 38.38; H, 3.94;
N, 9.95. Found: C, 38.13; H, 4.19; N, 9.59.
1
6b: 85%. H NMR (400 MHz, DMSO): d 7.49 (s, 4H, Im–H),
7.08 (s, 4H, Ph–H), 5.23 (s, 8H, –CH2–), 3.78 (s, 12H, Im–CH3),
3.52 (s, 6H, Ph–OCH3), 1.09 (s, 18H, t-Bu); 13C NMR (100 MHz,
DMSO-d6): d 179.40 (carbene), 152.22 (C–OCH3 of Ph), 146.95
(C–t-Bu of Ph), 128.68, 125.07, 121.94, 121.34, 117.97 (Im),
60.41 (OCH3), 48.07 (Im–CH2–Ph), 37.14 (Im–CH3), 32.94
(t-Bu), 29.73 (CH3 of t-Bu); ESI-MS: at m/z [M 2 2PF62]2+/2: at
m/z 459.3 (for 107Ag), 461.2 (for 109Ag). Anal. calcd for
{Bis[3-(N-9-anthrylmethylimidazol-2-yl)methyl-5-methyl-2-
methoxyphenyl]methane} hexafluorophosphate 5e: 73%. 1H
NMR (400 MHz, DMSO-d6): d 9.09 (s, 2H, NCHN), 8.86 (s, 2H,
An–H), 8.47 (d, 4H, J = 8.7 Hz, An–H), 8.23 (d, 4H, J = 8.7 Hz,
An–H), 7.69–7.60 (ddd, 12H, J = 14.7, 12.4, 7.1 Hz, An–H, Im–
H), 6.74 (d, 4H, J = 9.0 Hz, Ph–H), 6.53 (s, 4H, An–CH2), 5.30 (s,
4H, Im–CH2), 3.84 (s, 2H, Ph–CH2–Ph), 3.44 (s, 6H, 2-OCH3),
2.09 (s, 6H, Ph–CH3). 13C NMR (100 MHz, DMSO-d6): d 153.83
(C–OCH3 of Ph), 136.15 (NCHN of Im), 133.50, 133.41, 131.77,
131.08, 130.59, 130.15, 129.42, 128.04, 127.73, 127.67, 125.58,
C
42H56Ag2F12N8O2P2: C, 41.67; H, 4.66; N, 9.26, Found: C,
41.35; H, 4.96; N, 9.24.
6c: 70%. 1H NMR (400 MHz, DMSO-d6): d 7.92 (t, 8H, J = 8.2
Hz, Naph–H), 7.83 (d, 4H, J = 8.0 Hz, Naph–H), 7.62 (d, 4H, J =
1.2 Hz, Im–H), 7.49 (t, 4H, J = 7.5 Hz, Naph–H), 7.40 (m, 8H, J =
1.2 Hz, J = 6.8 Hz, Im–H, Naph–H), 7.28 (t, 4H, J = 7.6 Hz,
Naph–H), 7.22 (d, 4H, J = 6.8 Hz, Naph–H), 6.26 (s, 4H, Ph–H),
5.64 (s, 8H, Naph–CH2–Im), 4.89 (s, 8H, Im–CH2–Ph), 3.02 (s,
6H, –OCH3), 1.75 (s, 6H, –CH3); 13C NMR (100 MHz, DMSO-d6):
d 179.78 (carbene), 151.58 (C–OCH3 of Ph), 132.51, 132.37,
6958 | CrystEngComm, 2013, 15, 6948–6962
This journal is ß The Royal Society of Chemistry 2013